Advanced Biomed Inc. Common Stock (ADVB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.89K | -15.81K | -20.39K | -58.65K | -3.41M | -841.84K | -29.68K | -475.83K | -1.07M | 34.28K | -619.14K | 174.12K | -706.36K | -1.53M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 99.8% | 98.12% | 31.3% | 87.67% | -219.95% | -2555.49% | 95.21% | -373.28% | -50.87% | - | - | 111.38% | - | - |
| Net Income | -15.46K | 225.59K | -386.9K | -22.74K | -42.08K | -907.9K | -265.58K | -809.39K | -932.81K | -145.34K | -771.32K | -1.68M | -518.11K | -2.7M |
| Depreciation & Amortization | 295 | 466 | 47.99K | 2.09K | 2.38K | 99.07K | 102.22K | 153.91K | 118.46K | 73.37K | 89.31K | 166.99K | 31.36K | 114.38K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 888 | -261.6K | 327.59K | -4.11K | -3.31M | 0 | 0 | 0 | -241.34K | 0 | 0 | 150.21K | 0 | 1.66M |
| Working Capital Changes | 7.38K | 19.73K | -9.07K | -33.88K | -64.03K | -33.01K | 133.68K | 179.65K | -9.98K | 106.26K | 62.87K | 1.54M | -219.62K | -601.52K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 19.97K | 14 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.48K | -2.92K | -7.77K | -6.82K | 207 | -83.32K | 173.75K | 184.09K | 0 | 286.68K | 91.33K | 1.4M | -265.93K | -1.14M |
| Cash from Investing | -31 | -413 | -59 | -676 | -2.21K | 10.69K | -19.98K | -53.26K | 26.7K | -47.55K | 0 | -200.64K | 87.84K | -276.25K |
| Capital Expenditures | -31 | -413 | -59 | -676 | -63 | 10.69K | -19.98K | -13.28K | -13.28K | -47.55K | 0 | -210.88K | 150.21K | -287.37K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | -2.15K | 0 | 0 | -39.98K | 39.98K | 0 | 0 | 10.24K | -62.37K | 11.13K |
| Cash from Financing | 8.02K | 9.63K | 14.95K | -11.35K | 5.9M | 408.29K | 392.52K | 323.54K | 562.2K | 667.88K | 313.21K | -541.86K | 412.94K | 6.1M |
| Debt Issued (Net) | 567 | -11.05K | 14.95K | 14.28K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 7.84K | 0 | 0 | 7.74K | 171.37K | -519 | -519 | 0 | 0 | -1.05K | 0 | 11.61K | -11.61K | 6.1M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -390 | 20.68K | 0 | -33.36K | 5.73M | 408.81K | 393.04K | 323.54K | 562.2K | 668.93K | 313.21K | -553.47K | 424.55K | 0 |
| Net Change in Cash | -1.49K | -4.26K | -12.25K | -56.73K | 2.53M | 10.24K | 39.02K | -55.73K | -112.92K | 189.4K | -35.06K | 92.78K | -397.16K | 4.49M |
| Free Cash Flow | -6.93K | -16.23K | -20.45K | -59.32K | -3.41M | -831.15K | -49.66K | -529.08K | -1.04M | -13.27K | -619.14K | -36.76K | -556.15K | -2.24M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 99.8% | 98.05% | 58.82% | 88.79% | -228.39% | -6163.84% | 91.98% | -1339.18% | -86.81% | - | - | 98.36% | - | - |
| FCF per Share | -0.01 | -0.00 | -0.00 | -0.05 | -0.17 | -0.04 | -0.00 | -0.53 | -0.01 | -0.00 | -0.00 | - | - | - |
| FCF Conversion (FCF/Net Income) | 0.45x | -0.07x | 0.05x | 2.58x | 2.46x | 29.99x | 0.11x | 0.59x | 1.01x | -0.24x | 0.80x | -0.10x | 1.36x | 0.57x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |